Source link : https://www.newshealth.biz/health-news/no-benefit-to-anticoagulation-after-stemi-revascularization/
LONDON — There appears to be no advantage for continuing anticoagulation treatment after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), according to the results of a large randomized controlled trial presented at the European Society of Cardiology (ESC) Congress 2024 on August 31. Updated data from the RIGHT trial showed that at […]
Author : News Health
Publish date : 2024-09-12 12:36:08
Copyright for syndicated content belongs to the linked Source.